SCHEMBL12834700

SCHEMBL12834700

CCCc1ccc(-c2ccc(-c3ccc(-c4ccc(C)c(F)c4C(F)F)cc3)cc2)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RARB P10826 2/20 0.34
MCL1 Q07820 1/20 0.33
MPL P40238 2/20 0.32
TSHR P16473 1/20 0.32
HSD17B10 Q99714 1/20 0.32
GRIA4 P48058 1/20 0.32
NISCH Q9Y2I1 1/20 0.31
LPL P06858 1/20 0.31
LIPG Q9Y5X9 1/20 0.31
ACACB O00763 1/20 0.31
ACACA Q13085 1/20 0.31
MAPT P10636 2/20 0.31
ALOX5 P09917 1/20 0.31
NPC1 O15118 1/20 0.31
RAB9A P51151 1/20 0.31
GFER P55789 1/20 0.31
MAOB P27338 1/20 0.30
CNR1 P21554 1/20 0.30
CNR2 P34972 1/20 0.30
MEN1 O00255 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13025699 1.00 RARB (0.34) RARBMCL1MPLTSHRHSD17B10
SCHEMBL12834628 0.98 RARB (0.35) RARBMCL1MPLHSD17B10GRIA4
SCHEMBL13025689 0.87 MPL (0.35) RARBMPLGRIA4NISCHLPL
SCHEMBL12834586 0.85 MPL (0.34) RARBMPLGRIA4NISCHLPL
SCHEMBL13025972 0.84 FFAR4 (0.34) RARBMPLGRIA4NISCHCNR2
SCHEMBL12834677 0.84 MPL (0.35) RARBMPLHSD17B10GRIA4NISCH
SCHEMBL13986085 0.83 RARB (0.38) RARBMCL1MPLNISCHLPL
SCHEMBL17614863 0.83 RARB (0.38) RARBMCL1MPLNISCHLPL
SCHEMBL12172447 0.81 RARB (0.38) RARBMCL1MPLHSD17B10NISCH
SCHEMBL17616206 0.80 RARB (0.38) RARBMCL1MPLNISCHLPL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1731493-B1 BENZENE DERIVATIVE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY CHISSO CORP (JP) 2011-03-23 EP disclosed
US-7838087-B2 Benzene derivative, liquid crystal composition and liquid crystal display device CHISSO CORPORATION (JP) 2010-11-23 US disclosed
US-7838087-B2 Benzene derivative, liquid crystal composition and liquid crystal display device CHISSO CORPORATION (JP) 2010-11-23 US disclosed
US-20070200092-A1 Benzene Derivative, Liquid Crystal Composition And Liquid Crystal Display Device JNC PETROCHEMICAL CORPORATION (JP) 2007-08-30 US disclosed
US-20070200092-A1 Benzene Derivative, Liquid Crystal Composition And Liquid Crystal Display Device JNC PETROCHEMICAL CORPORATION (JP) 2007-08-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070200092-A1 Benzene Derivative, Liquid Crystal Composition And Liquid Crystal Display Device CCND2, YBX1, CNKSR1 RARB 228/4885MCL1 1558/4885MPL 4668/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.